RecruitingNCT06648577

3D Ultrasound Myocardial Mechanical Wave Measurements

3D Ultrasound Myocardial Mechanical Wave Measurements in Primary Mitral Regurgitation


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

40 participants

Start Date

Oct 9, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Primary mitral regurgitation (MR) is a frequent disease that can ultimately lead to heart failure. Primary MR represents the second most prevalent cause of cardiac valve surgery in high income countries. Progressive myocardial fibrosis due to chronic volume overload is recognized as a pathophysiological substrate of altered LV function in primary MR. As fibrosis leads to increased myocardial stiffness, ultrasound mechanical wave propagation measurements within the myocardium could provide important clinical information. Natural mechanical wave velocity (MWV) imaging, using High-frame-rate (HFR) echocardiography has emerged as a promising tool to evaluate myocardial stiffness. The objective is study is to evaluate the correlation between the LV myocardial stiffness (as assessed by 3D ultrasound myocardial MWV mapping) and myocardial interstitial fibrosis as measured using CMR (myocardial extracellular volume measure)


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Severe primary MR patients (effective regurgitation orifice area ≥ 40mm²) with class I indication for surgery (symptoms and/or altered conventional parameters of LV function) (n=10 patients)
  • Severe primary MR patients (effective regurgitation orifice area ≥ 40mm²) without class I indication of surgery (n=20 patients)
  • Mild to moderate primary MR patients as defined by effective regurgitation orifice area ≥ 20mm² and < 40mm² (n=10 patients)

Exclusion Criteria7

  • Permanent atrial fibrillation
  • Acute primary severe MR
  • Secondary MR
  • Previous cardiac surgery of any kind
  • Other severe left sided valvular disease
  • Coronary artery disease
  • Congenital cardiac disorder

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREUltrasound imaging

The participants are scanned with an ultrasound scanner


Locations(2)

Pitié Salpêtrière hospital

Paris, Paris, France

Pitié- Salpêtrière hospital (AP-HP)

Paris, Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06648577